EUVIMEDEUVIMED entdecken
Open Access

Recruited Monocyte-Derived Macrophages Drive T Cell Inflammation in Immune Checkpoint Inhibitor-Mediated Pneumonitis

Xiaoran Cui iD, Renyong Zhi iD, Xiaoyan Li, Yinming Ji, Zhisong Hu, Pengfei Cui, Yuhui Qin, Tao Li, Liangliang Wu, Lingxiong Wang, Jinfeng Li, Yibing Bai und 3 weitere

Cancer Communications · 2026

DOI: 10.34133/cancomm.0049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Communications, 2026. Verfasst von Xiaoran Cui und 14 weiteren Autor:innen. Beteiligte Einrichtung: Senior Department of Oncology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, P. R. China. Hauptthemen laut MEDLINE: Macrophages, Immune Checkpoint Inhibitors, Pneumonia, T-Lymphocytes. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the Noncommunicable Chronic Diseases-National Science and Technology Major Project, the Major Research Program of the National Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immune checkpoint inhibitor-mediated pneumonitis (CIP) constitutes a major toxicity that limits the clinical application of cancer immunotherapy, whereas its underlying mechanisms remain incompletely understood. Current management relies on nonspecific immunosuppressants, lacking precision therapies. Although single-cell RNA sequencing (scRNA-seq) of bronchoalveolar lavage fluid (BALF) has implicated T cell activation and inflammatory myeloid responses in CIP pathogenesis, critical gaps persist regarding interstitial lung immunity and mechanisms governing monocyte/macrophage–T cell co-enrichment and crosstalk. We aimed to delineate the lung immune circuits that drive CIP and to identify targetable monocyte/macrophage–T cell pathways that could be leveraged for precision intervention.

Methods

To elucidate CIP pathogenesis, we performed integrated scRNA-seq analysis of BALF from CIP + and CIP − patients with validation in a prospective cohort using flow cytometry, enzyme-linked immunosorbent assay, Western blotting, and quantitative polymerase chain reaction. Mechanistic studies were performed using an established tumor-bearing forkhead box P3–diphtheria toxin receptor–green fluorescent protein ( Foxp3-DTR-GFP ) mouse model of programmed death-1 inhibitor-induced CIP via micro-computed tomography, histopathology, scRNA-seq, flow cytometry, multiplex immunofluorescence, Western blotting, Transwell migration assays, and pharmacologic interventions.

Results

In CIP + patient BALF and mouse lung tissues, CD8 + T cells expressing cytotoxic effectors and C-X-C chemokine receptor 3 (CXCR3) expanded concomitantly with distinct C-C chemokine receptor 2 (CCR2) + monocyte-derived macrophages (MoMΦ) exhibiting a highly inflammatory phenotype, while tissue-resident macrophages were markedly reduced. Mouse models revealed that expanded CCR2 + MoMΦ originating from circulation replenished the depleted niche of lung-resident interstitial macrophages. Mechanistically, integrated in silico prediction and experimental validation demonstrated that CCR2 + MoMΦ recruited CD8 + T cells via the C-X-C motif chemokine ligand 9/10 (CXCL9/10)–CXCR3 axis. Conversely, CD8 + T cells drove CCR2 + MoMΦ expansion and pro-inflammatory phenotype via the interferon-γ (IFN-γ) axis, suggesting the existence of a positive feedback loop between these cell types. Pharmacological targeting of CCR2/CCR5 or CXCR3 signaling attenuated pneumonitis, reduced pulmonary CCR2 + MoMΦ infiltration, diminished pathogenic T cell activation and cytotoxicity, and improved survival without compromising antitumor immunity.

Conclusions

Our findings establish CCR2 + MoMΦ and the IFN-γ–CXCL9/10–CXCR3 axis as core drivers of CIP pathogenesis and validate their therapeutic targeting potential. This work provides a scientific foundation for developing CIP-specific prevention and treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesImmune Checkpoint InhibitorsPneumoniaT-LymphocytesAnimalsHumansMiceReceptors, CCR2Receptors, CXCR3Bronchoalveolar Lavage FluidFemaleChemokine CXCL10Disease Models, AnimalMonocytesInflammationCD8-Positive T-Lymphocytes

Substanzen

Immune Checkpoint InhibitorsReceptors, CCR2Receptors, CXCR3CXCR3 protein, humanChemokine CXCL10CCR2 protein, humanCcr2 protein, mouse

Autor:innen und Institutionen

  • Senior Department of Oncology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, P. R. China.
  • Institute of Oncology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, P. R. China.
  • Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, P. R. China.
  • Department of Oncology, the Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, P. R. China.
  • Department of Oncology, the Second Medical Center of Chinese PLA General Hospital, Beijing, P. R. China.
  • Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing, P. R. China.

ORCID-Profile: Xiaoran Cui, Renyong Zhi, Tianyi Liu, Yi Hu

Förderung

  • the Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • the Major Research Program of the National Health Commission

Zitieren

APA

Cui, X., Zhi, R., Li, X., Ji, Y., Hu, Z., Cui, P., Qin, Y., Li, T., Wu, L., Wang, L., Li, J., Bai, Y., Li, H., Liu, T., & Hu, Y. (2026). Recruited Monocyte-Derived Macrophages Drive T Cell Inflammation in Immune Checkpoint Inhibitor-Mediated Pneumonitis. Cancer Communications. https://doi.org/10.34133/cancomm.0049

Vancouver

Cui X, Zhi R, Li X, Ji Y, Hu Z, Cui P, et al. Recruited Monocyte-Derived Macrophages Drive T Cell Inflammation in Immune Checkpoint Inhibitor-Mediated Pneumonitis. Cancer Communications. 2026. doi:10.34133/cancomm.0049

BibTeX
@article{Cui2026,
  author = {Cui, Xiaoran and Zhi, Renyong and Li, Xiaoyan and Ji, Yinming and Hu, Zhisong and Cui, Pengfei and Qin, Yuhui and Li, Tao and Wu, Liangliang and Wang, Lingxiong and Li, Jinfeng and Bai, Yibing and Li, Hui and Liu, Tianyi and Hu, Yi},
  title = {Recruited Monocyte-Derived Macrophages Drive T Cell Inflammation in Immune Checkpoint Inhibitor-Mediated Pneumonitis},
  journal = {Cancer Communications},
  year = {2026},
  doi = {10.34133/cancomm.0049}
}
Kostenlos starten →